A review of FDA approved drugs and their formulations for the treatment of breast cancer.

Chaurasia, Mohini; Singh, Romi; Sur, Srija; Flora, S J S

Chaurasia, Mohini; Singh, Romi; Sur, Srija; Flora, S J S.

Afiliación

Chaurasia M; Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, India.
Singh R; Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, India.
Sur S; Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, India.
Flora SJS; Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, India.

Front Pharmacol ; 14: 1184472, 2023.

Article en En | MEDLINE | ID: mdl-37576816

Palabras clave

FDA; breast cancer; cytotoxic drugs; formulations; hormonal and targeted drugs; liposomes; nanoemulsion; nanoformulation

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google